Heverlee / Liège / Hilden / Rockville / Forster City / Palo Alto / Madison / Leuven / Mannheim / Steinheim / Indianapolis / Foster City / Zoeterwoude / Verviers / San Diego / Erembodegem / Arlington / /
Company
Millipore Corp. / F. Bentzien L.C. / Roche Clinical Laboratories / Avanti Polar Lipids Inc / Sigma-Aldrich / Invitrogen Corp. / Proc Natl Acad Sci U S A / D. Kumar S.A. / S. Blacher S.P. / GraphPad Software / QIAGEN / Polysciences Inc. / Polar Lipids Inc. / BD Biosciences / Int J Pharm / Amersham Biosciences / /
Country
Germany / Netherlands / Belgium / France / United States / /
Facility
University of Liège / HRP complex / Central Animal Facility of CHU Liège / Laboratory of Tumor / /
IndustryTerm
therapy of cancer / liposome solution / cancer therapy / cancer therapies / cell culture media / cancer treatment / treatment of cancer / Image processing / /
MedicalCondition
histological tumor / mg tumor / control tumors / metastasis / immunohistochemistry Tumors / B16-F10 melanoma / immunostain tumor / subcutaneous B16F10 mouse melanoma / human melanoma / melanoma / B16F10 tumors / human HCT116 colon cancer / chronic inflammation / numerous disorders / each tumor / prostate cancer / breast cancer / B16BL6 tumor / median tumor / tumor / B16F10 melanoma / cardiomyopathy / cancer / tumors / disease / mouse tumors / s.c. B16F10 mouse melanoma / solid tumor / postpartum cardiomyopathy / B16F10 metastasis / subcutaneous tumor / Nat Rev Cancer / injected tumor / mean tumor / How tumors / B16BL6 tumors / 16K hPRL-treated tumors / B16F10 murine melanoma / B16F10 mouse melanoma / nascent tumors / primary tumor / /
Center of Numerical Molecular Biophysics / Laboratory of Tumor and Development Biology / Laboratory of Tumor / University of Liège / FDA / GIGA-Research / Molecular Biology and Genetic Engineering Unit / /
Person
Laurence Lins / N. Bouck / V / Isabelle Dasoul / Michelle Lion / Sakura Finetek / F. Lopez-Barrera / V / F. Rentier-Delrue / V / M. Luchtefeld / V / Judah Folkman / V. Poli / Christelle Flore / G. D'Angelo / G. Martinez de la Escalera / /
* Manuscript Antiangiogenic liposomal gene therapy with 16K human prolactin efficiently reduces tumor growth. Virginie Kinet1, Ngoc-Quynh-Nhu Nguyen1, Céline Sabatel1, Silvia Blacher2, Agnès Noël2, Joseph A Martial1